metastatic castration-resistant prostate cancer

Metastatic castration-resistant prostate cancer (mCRPC) is an advanced form of prostate cancer that has spread beyond the prostate gland to other parts of the body. Despite treatments that lower testosterone levels (castration), which normally help control prostate cancer growth, this cancer continues to grow and spread. It is more difficult to treat than earlier-stage prostate cancer and requires specialized therapies. Researchers are continually working on new treatments to improve outcomes and quality of life for patients with mCRPC.